Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-001423
Accepted
2020-06-16 00:15:17
Documents
1
Effectiveness Date
2020-06-15
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-20-001423.txt   2003
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: EFFECT | Act: 33 | File No.: 333-235889 | Film No.: 20964881
SIC: 2834 Pharmaceutical Preparations